OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
15
Results
Show all
Save search
Copy query
Show results for
Unknown
(15)
Publication Date
Release Date
2024
(5)
2022
(2)
2021
(2)
2019
(2)
2025
(1)
2023
(1)
2017
(1)
2016
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
ALPK2 acts as tumor promotor in development of bladder cancer through targeting DEPDC1A.
Not available
S-EPMC8249393
|
biostudies-literature
Cite
Filamentation initiated by Cas2 and its association with the acquisition process in cells.
Not available
S-EPMC6802651
|
biostudies-literature
Cite
Facial aging, cognitive impairment, and dementia risk.
Not available
S-EPMC11539626
|
biostudies-literature
Cite
Habitat-based radiomics analysis for evaluating immediate response in colorectal cancer lung metastases treated by radiofrequency ablation.
Not available
S-EPMC10964536
|
biostudies-literature
Cite
Multi-Omics Profiles of Small Intestine Organoids in Reaction to Breast Milk and Different Infant Formula Preparations.
Not available
S-EPMC11397455
|
biostudies-literature
Cite
The SNP rs516946 Interacted in the Association of MetS with Dietary Iron among Chinese Males but Not Females.
Not available
S-EPMC9147551
|
biostudies-literature
Cite
How COVID-19 lockdown and reopening affected daily steps: evidence based on 164,630 person-days of prospectively collected data from Shanghai, China.
Not available
S-EPMC7968558
|
biostudies-literature
Cite
Real-world data of triplet combination of pyrotinib, trastuzumab, and chemotherapy in HER2-positive metastatic breast cancer: a multicenter, retrospective study.
Not available
S-EPMC10748899
|
biostudies-literature
Cite
Health-related quality of life of postmenopausal Chinese women with hormone receptor-positive early breast cancer during treatment with adjuvant aromatase inhibitors: a prospective, multicenter, non-interventional study.
Not available
S-EPMC4806477
|
biostudies-literature
Cite
Real-world comparison of palbociclib, abemaciclib, and dalpiciclib as first-line treatments for Chinese HR+/HER2-metastatic breast cancer patients: a multicenter study (YOUNGBC-28).
Not available
S-EPMC11653472
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets